IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)
Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –
IRadimed price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
IRadimed's price to book ratio was 10.9× on Nov 11, 2026, against 12.1× a year earlier. Over the last 5 years it ranged from 5.1× to 14.0×, with a median of 8.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.9× | −1.7 |
| 2025 | Dec 31, 2025 | 12.6× | +4.2 |
| 2024 | Dec 31, 2024 | 8.4× | +0.3 |
| 2023 | Dec 29, 2023 | 8.0× | +2.9 |
| 2022 | Dec 30, 2022 | 5.1× | −3.3 |
| 2021 | Dec 31, 2021 | 8.4× | +3.8 |
| 2020 | Dec 31, 2020 | 4.6× | −0.6 |
| 2019 | Dec 31, 2019 | 5.2× | −1.5 |
| 2018 | Dec 31, 2018 | 6.7× | +1.7 |
| 2017 | Dec 29, 2017 | 5.0× | +1.1 |
| 2016 | Dec 30, 2016 | 3.9× | −7.2 |
| 2015 | Dec 31, 2015 | 11.0× | +4.2 |
| 2014 | Dec 31, 2014 | 6.9× | – |
See a number that looks wrong?